ArticleJournal of translational medicine2026
Dual-block HER2 assessment reveals clinically relevant intratumoral heterogeneity in gynecologic cancers: a single-center landscape analysis.
Xiaonan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.